🇺🇸 FDA
Company

Cue

Cue Biopharma

CUE biotech USA

Quick answer

Cue is a biotech company (CUE) headquartered in BOSTON, MA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

CUE-101

Head and Neck Squamous Cell Carcinoma

Phase 2 · small_molecule · active

1 trials project

CUE-101

Oropharyngeal Squamous Cell Carcinoma

Phase 2 · small_molecule · active

1 trials project

CUE-101

Head and Neck Cancer

Phase 1 · small_molecule · completed

1 trials project

CUE-102

Colorectal Cancer

Phase 1 · small_molecule · completed

1 trials project

CUE-102

Recurrent Glioblastoma

Phase 1 · mab · active

1 trials

Patents (8)

patent

US 12421287

T-cell modulatory multimeric polypeptides and methods of use thereof

Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12257311

Multimeric T-cell modulatory polypeptides and methods of use thereof

Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12180258

T-cell modulatory multimeric polypeptides and methods of use thereof

Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12152061

T-cell modulatory multimeric polypeptides and methods of use thereof

Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12145973

T-cell modulatory multimeric polypeptides and methods of use thereof

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12029782

MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabe

Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12006348

T-cell modulatory multimeric polypeptide with conjugation sites and methods of u

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11993641

Methods for modulating an immune response

Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)